Plonmarlimab, a novel anti‐GM‐CSF blocking antibody, ameliorates disease progression in the pre‐clinical model of macrophage activation syndrome.
Saved in:
| Title: | Plonmarlimab, a novel anti‐GM‐CSF blocking antibody, ameliorates disease progression in the pre‐clinical model of macrophage activation syndrome. |
|---|---|
| Authors: | Ding, Jian1 (AUTHOR), Xu, Ke1 (AUTHOR), Niu, Yanling1 (AUTHOR), Qin, Yihui1 (AUTHOR), Shen, Hong2 (AUTHOR), Wang, Yajuan1 (AUTHOR), Guo, Wenyu1 (AUTHOR), Liu, Xuejun1 (AUTHOR), Wang, Zhengyi1 (AUTHOR), Zhu, Andrew X.1 (AUTHOR) andrew.zhu@tjbio.com |
| Source: | Immunology. Nov2024, Vol. 173 Issue 3, p552-561. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
